Curis stock analysis
WebApr 7, 2024 · Curis, Inc.’s trailing 12-month revenue is $10.2 million with a -557.7% profit margin. Year-over-year quarterly sales growth most recently was -6.5%. Analysts expect adjusted earnings to reach $-0.408 per share for the current fiscal year. Curis, Inc. does not currently pay a dividend. The Biotechnology and Medical Research sub-industry has a ... WebMay 12, 2024 · Currently, Curis is a Zacks Rank #5 (Strong Sell) in the Medical – Biomedical and Genetics industry that ranks in Bottom 11% of our Zacks Industry Rank. Over the last 60 days, no analysts have...
Curis stock analysis
Did you know?
WebMar 13, 2024 · Curis stock soars 34% as FDA lifts partial clinical hold on emavusertib's lymphoma study Aug 18. Price target increased to US$17.67 Aug 06. Curis, Inc. Appoints Diantha Duvall as Chief Financial Officer, Treasurer, Assistant Secretary, Principal Financial Officer and Principal Accounting Officer of the Company Effective as of August 5, 2024 ... WebApr 9, 2024 · What is Curis' stock price forecast for 2024? 2 equities research analysts have issued 1-year target prices for Curis' stock. Their CRIS share price forecasts range from …
WebMar 10, 2024 · Stock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for Curis stock is $ 6.89 , which predicts an increase of 996.26%. … WebProvide the latest Biotechnology (BK2069) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company introduction, dividends and dividend information, you can also use Moomoo to open an account to trade Biotechnology stocks，we will provide investors with reference decision data.
WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … Web1 day ago · Stock Evaluator: Curis, Inc. (CRIS) + Follow This Stock $0.55 -0.01 -1.04% December 30, 2024 4:00:01 PM EST Volume: 649,252 USD NASD DELAYED PRICE News & Events A+ Stock Grade Summary: VALUE: GROWTH: MOMENTUM: EPS REVISIONS: QUALITY: Click here to access A+ stock grades COMPANY SUMMARY …
WebMar 13, 2024 · Curis stock soars 34% as FDA lifts partial clinical hold on emavusertib's lymphoma study Aug 18. Price target increased to US$17.67 Aug 06. Curis, Inc. …
WebApr 12, 2024 · The present stock price for Curis Inc. (CRIS) is $0.76. In the last trading session, the stock made a considerable jump, reaching $0.7694 after an opening price … church street medical centre begaWebApr 6, 2024 · According to analysts, Curis's stock has a predicted upside of 616.29% based on their 12-month price targets. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings European Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated … dexamfetamine sulfate half lifeWebCRIS Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for Curis in the last 3 months. The average price target is $7.00 with a high … church street medical centre coatbridgeWebAug 31, 2024 · The stock, however, recovered in pre-market trading on Wednesday. Curis’ stock has declined 78.8% this year compared with the industry’s decrease of 24.4%. Zacks Investment Research church street medWebThe high in the last 52 weeks of Curis stock was 2.63. According to the current price, Curis is 20.65% away from the 52-week high. What are analysts forecasts for Curis stock? The 3 analysts ... dexamol cold infantWebApr 12, 2024 · Curis (CRIS) Down on FDA Partial Clinical Hold on Lymphoma Study Contributor Zacks Equity Research Zacks Published Apr 12, 2024 11:57AM EDT Shares of Curis, Inc. CRIS were down 8.3% on Monday... dexam hand towelsWebApr 11, 2024 · View Curis, Inc CRIS investment & stock information. Get the latest Curis, Inc CRIS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. church street medical centre dundalk